Interethnic variability of ERCC2 polymorphisms
- PMID: 15534626
- DOI: 10.1038/sj.tpj.6500283
Interethnic variability of ERCC2 polymorphisms
Abstract
Excision Repair Cross-Complementing Rodent Repair Group 2 (ERCC2) plays an important role in DNA repair by eliminating bulky DNA adducts produced by platinum agents during the nucleotide excision repair pathway. Several studies have associated polymorphisms in ERCC2 with response to platinum therapy, lung cancer risk, and DNA repair capacity. This study examined ERCC2 polymorphisms and haplotype structure across 18.9 kb in 95 European, 95 African, and 95 Asian individuals. Single-nucleotide polymorphisms (SNPs) (ERCC2 -9164 A>T, -1989 A>G, -516 G>A, 468 C>A [Arg156Arg], 1737 C>T [Val579Val], 2133 C>T [Asp711Asp], and 2251 T>G [Lys751Gln]) were mined and mapped using Golden Path, PolyMAPr, and Promolign. Genotyping was performed using PCR and pyrosequencing. Allele frequencies ranged from 0 to 0.47 (Europeans), 0.05 to 0.72 (Africans), and 0 to 0.47 (Asians). The synonymous cSNP at codon 579 could not be confirmed in our populations. There were significant differences in haplotype structure and frequency between populations. This information on ERCC2 genomic structure will allow the construction of definitive studies to clarify the clinical role of this important gene.
Similar articles
-
A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population.Cancer Genet Cytogenet. 2007 May;175(1):47-51. doi: 10.1016/j.cancergencyto.2007.01.010. Cancer Genet Cytogenet. 2007. PMID: 17498557
-
ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2059-64. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598761
-
Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):359-65. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12692111
-
ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review.Am J Epidemiol. 2005 Jan 1;161(1):1-14. doi: 10.1093/aje/kwi018. Am J Epidemiol. 2005. PMID: 15615908 Review.
-
Comprehensive assessment of associations between ERCC2 Lys751Gln/Asp312Asn polymorphisms and risk of non- Hodgkin lymphoma.Asian Pac J Cancer Prev. 2014;15(21):9347-53. doi: 10.7314/apjcp.2014.15.21.9347. Asian Pac J Cancer Prev. 2014. PMID: 25422223 Review.
Cited by
-
Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis.Tumour Biol. 2014 Jun;35(6):5245-57. doi: 10.1007/s13277-014-1682-x. Epub 2014 Feb 7. Tumour Biol. 2014. PMID: 24504678
-
Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans.Int J Cancer. 2008 Nov 1;123(9):2095-104. doi: 10.1002/ijc.23801. Int J Cancer. 2008. PMID: 18709642 Free PMC article.
-
DNA Repair Gene Polymorphisms in the Nucleotide Excision Repair Pathway and Lung Cancer Risk: A Meta-analysis.Chin J Cancer Res. 2011 Jun;23(2):79-91. doi: 10.1007/s11670-011-0079-2. Chin J Cancer Res. 2011. PMID: 23482879 Free PMC article.
-
Pharmacogenomic assessment of Mexican and Peruvian populations.Pharmacogenomics. 2015;16(5):441-8. doi: 10.2217/pgs.15.10. Pharmacogenomics. 2015. PMID: 25916516 Free PMC article.
-
Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1.Mol Cancer Ther. 2008 May;7(5):1246-50. doi: 10.1158/1535-7163.MCT-07-2206. Mol Cancer Ther. 2008. PMID: 18483312 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials